Zimmer Biomet announced Tuesday it has completed the acquisition of Monogram Technologies Inc., billed as an AI-driven, next-generation robotics company.

Zimmer Biomet, based in Warsaw, said the previously announced deal expands its portfolio and creates a path for it to become the first orthopedic company to offer a fully autonomous robotic solution.

When announced in July, the equity deal was valued at $177 million. Monogram Technologies is based in Austin, Texas.

By 2030, an estimated 4 million people in the U.S. will need a joint replacement, driven by an aging and more active population creating unprecedented demand for consistent surgical outcomes, a news release said.

Monogram’s CT-based semi-autonomous knee arthroplasty technology recently received FDA 501(k) clearance. The tec

See Full Page